NCT06805305: An ongoing trial by Diakonos Oncology Corporation
This trial is ongoing. It must report results 4 years, 12 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06805305 |
|---|---|
| Title | Randomized Study of DOC1021 Dendritic Cell Immunotherapy in Combination With Standard of Care for Newly Diagnosed Adult Glioblastoma |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 17, 2025 |
| Completion date | March 31, 2030 |
| Required reporting date | March 31, 2031, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |